The Advisory Team at Bryn Pharma is comprised of experts who provide strategic guidance and scientific insights to support the development, regulatory approval, and market positioning of the company’s nasal-based epinephrine products. This team plays a critical role in ensuring that Bryn Pharma's offerings are safe, effective, and well-received by both medical professionals and patients.
Allan Luskin
Scientific Advisor
Bradley Chipps
Scientific Advisor
Carlos Camargo
Scientific Advisor
Matthew L. Mintz
Scientific Advisor
Michael B. Foggs
Scientific Advisor
Phillip Korenblat
Scientific Advisor
Ronna Campbell
Scientific Advisor
Ruchi S. Gupta
Scientific Advisor
Scott Russell
Scientific Advisor
William W. Storms
Scientific Advisor
View all